Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 2
2011 7
2012 7
2013 11
2014 10
2015 9
2016 4
2017 9
2018 7
2019 14
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Salloum NC, et al. Among authors: hoeppner b. Depress Anxiety. 2019 Mar;36(3):235-243. doi: 10.1002/da.22875. Epub 2018 Dec 30. Depress Anxiety. 2019. PMID: 30597688 Clinical Trial.
Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy.
Kelly JF, Bergman B, Hoeppner BB, Vilsaint C, White WL. Kelly JF, et al. Among authors: hoeppner bb. Drug Alcohol Depend. 2017 Dec 1;181:162-169. doi: 10.1016/j.drugalcdep.2017.09.028. Epub 2017 Oct 18. Drug Alcohol Depend. 2017. PMID: 29055821 Free PMC article.
Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.
Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M. Freeman MP, et al. Among authors: hoeppner b. J Psychiatr Res. 2019 Mar;110:166-171. doi: 10.1016/j.jpsychires.2019.01.010. Epub 2019 Jan 8. J Psychiatr Res. 2019. PMID: 30641350 Free PMC article. Clinical Trial.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Fava M, et al. Among authors: hoeppner bb. Mol Psychiatry. 2020 Jul;25(7):1592-1603. doi: 10.1038/s41380-018-0256-5. Epub 2018 Oct 3. Mol Psychiatry. 2020. PMID: 30283029 Free PMC article.
A pilot randomized clinical trial testing integrated 12-Step facilitation (iTSF) treatment for adolescent substance use disorder.
Kelly JF, Kaminer Y, Kahler CW, Hoeppner B, Yeterian J, Cristello JV, Timko C. Kelly JF, et al. Among authors: hoeppner b. Addiction. 2017 Dec;112(12):2155-2166. doi: 10.1111/add.13920. Epub 2017 Aug 1. Addiction. 2017. PMID: 28742932 Free PMC article. Clinical Trial.
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial.
Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Brown HE, et al. Among authors: hoeppner b. JAMA Psychiatry. 2019 Jul 1;76(7):691-699. doi: 10.1001/jamapsychiatry.2019.0151. JAMA Psychiatry. 2019. PMID: 30916714 Free PMC article. Clinical Trial.
Lived Experience in New Models of Care for Substance Use Disorder: A Systematic Review of Peer Recovery Support Services and Recovery Coaching.
Eddie D, Hoffman L, Vilsaint C, Abry A, Bergman B, Hoeppner B, Weinstein C, Kelly JF. Eddie D, et al. Among authors: hoeppner b. Front Psychol. 2019 Jun 13;10:1052. doi: 10.3389/fpsyg.2019.01052. eCollection 2019. Front Psychol. 2019. PMID: 31263434 Free PMC article.
Development of the State Optimism Measure.
Millstein RA, Chung WJ, Hoeppner BB, Boehm JK, Legler SR, Mastromauro CA, Huffman JC. Millstein RA, et al. Among authors: hoeppner bb. Gen Hosp Psychiatry. 2019 May-Jun;58:83-93. doi: 10.1016/j.genhosppsych.2019.04.002. Epub 2019 Apr 4. Gen Hosp Psychiatry. 2019. PMID: 31026732 Free PMC article.
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression.
Salloum NC, Fava M, Hock RS, Freeman MP, Flynn M, Hoeppner B, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Salloum NC, et al. Among authors: hoeppner b. J Affect Disord. 2020 Jan 1;260:131-139. doi: 10.1016/j.jad.2019.09.017. Epub 2019 Sep 3. J Affect Disord. 2020. PMID: 31494365
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).
Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI. Fava M, et al. Among authors: hoeppner bb. Brain Stimul. 2018 Jan-Feb;11(1):75-84. doi: 10.1016/j.brs.2017.09.010. Epub 2017 Sep 23. Brain Stimul. 2018. PMID: 29030111 Free PMC article. Clinical Trial.
72 results
Jump to page
Feedback